| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.827 | 0.002 | 0.849 | Anesthetic general | 0.849 0.002 DBMET00592 0.799 0.002 DBMET00593 0.717 0.003 DBMET00601 | DBMET00592 | |
| 0.799 | 0.001 | 0.799 | Androgen agonist | 0.338 0.003 DBMET00592 0.203 0.005 DBMET00593 0.34 0.003 DBMET00601 | ||
| 0.806 | 0.014 | 0.934 | Antiinflammatory | 0.913 0.005 DBMET00592 0.888 0.005 DBMET00593 0.934 0.005 DBMET00601 | DBMET00601 | |
| 0.788 | 0.002 | 0.788 | Androgen antagonist | 0.172 0.017 DBMET00592 0.151 0.022 DBMET00593 0.216 0.012 DBMET00601 | ||
| 0.788 | 0.005 | 0.788 | Aldehyde oxidase inhibitor | 0.214 0.097 DBMET00593 | ||
| 0.788 | 0.004 | 0.962 | Cholesterol antagonist | 0.962 0.001 DBMET00592 0.926 0.002 DBMET00593 0.947 0.001 DBMET00601 | DBMET00592 | |
| 0.799 | 0.017 | 0.842 | Apoptosis agonist | 0.842 0.012 DBMET00592 0.838 0.012 DBMET00593 0.838 0.012 DBMET00601 | DBMET00592 | |
| 0.788 | 0.014 | 0.942 | Transcription factor NF kappa B inhibitor | 0.937 0.004 DBMET00592 0.909 0.005 DBMET00593 0.942 0.003 DBMET00601 | DBMET00601 | |
| 0.771 | 0.015 | 0.836 | Caspase 9 stimulant | 0.749 0.018 DBMET00592 0.836 0.007 DBMET00593 0.806 0.01 DBMET00601 | DBMET00593 | |
| 0.715 | 0.002 | 0.715 | Aromatase inhibitor | 0.179 0.01 DBMET00592 0.075 0.03 DBMET00593 0.123 0.017 DBMET00601 | ||
| 0.701 | 0.003 | 0.701 | Estrogen agonist | 0.36 0.004 DBMET00592 0.463 0.004 DBMET00593 0.348 0.005 DBMET00601 | ||
| 0.654 | 0.003 | 0.654 | Estrogen antagonist | 0.158 0.021 DBMET00592 0.256 0.008 DBMET00593 0.187 0.015 DBMET00601 | ||
| 0.645 | 0.008 | 0.793 | Nitric oxide antagonist | 0.793 0.004 DBMET00592 0.715 0.005 DBMET00593 0.705 0.005 DBMET00601 | DBMET00592 | |
| 0.625 | 0.002 | 0.625 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.605 | 0.001 | 0.605 | RNA-directed RNA polymerase stimulant | 0.274 0.002 DBMET00592 0.354 0.002 DBMET00593 0.274 0.002 DBMET00601 | ||
| 0.607 | 0.007 | 0.755 | Hypoxia-inducible factor 1 alpha inhibitor | 0.728 0.004 DBMET00592 0.624 0.006 DBMET00593 0.755 0.004 DBMET00601 | DBMET00601 | |
| 0.6 | 0.005 | 0.806 | Diuretic | 0.675 0.004 DBMET00592 0.696 0.004 DBMET00593 0.806 0.003 DBMET00601 | DBMET00601 | |
| 0.589 | 0.002 | 0.589 | Lipocortins synthesis antagonist | 0.453 0.005 DBMET00592 0.488 0.004 DBMET00593 0.584 0.002 DBMET00601 | ||
| 0.579 | 0.002 | 0.579 | Pregnane X receptor agonist | 0.137 0.08 DBMET00593 | ||
| 0.575 | 0.001 | 0.575 | Anabolic | 0.242 0.002 DBMET00592 0.206 0.004 DBMET00593 0.244 0.002 DBMET00601 | ||
| 0.566 | 0.002 | 0.566 | Sodium/bile acid cotransporter inhibitor | 0.481 0.005 DBMET00592 0.514 0.003 DBMET00593 0.511 0.004 DBMET00601 | ||
| 0.576 | 0.012 | 0.664 | Apoptosis antagonist | 0.623 0.007 DBMET00592 0.664 0.005 DBMET00593 0.635 0.006 DBMET00601 | DBMET00593 | |
| 0.567 | 0.004 | 0.567 | Phospholipase C inhibitor | 0.445 0.008 DBMET00592 0.488 0.006 DBMET00593 0.349 0.014 DBMET00601 | ||
| 0.553 | 0.003 | 0.553 | Neurotrophic factor enhancer | 0.368 0.008 DBMET00592 0.379 0.007 DBMET00593 0.368 0.008 DBMET00601 | ||
| 0.533 | 0.002 | 0.533 | Estradiol 17 beta-dehydrogenase inhibitor | 0.048 0.026 DBMET00601 | ||
| 0.547 | 0.021 | 0.645 | Immunosuppressant | 0.605 0.013 DBMET00592 0.591 0.014 DBMET00593 0.645 0.008 DBMET00601 | DBMET00601 | |
| 0.523 | 0.003 | 0.523 | Estrogen receptor beta agonist | 0.146 0.007 DBMET00592 0.218 0.004 DBMET00593 0.162 0.006 DBMET00601 | ||
| 0.516 | 0.006 | 0.689 | Hepatoprotectant | 0.68 0.004 DBMET00592 0.689 0.004 DBMET00593 0.653 0.004 DBMET00601 | DBMET00593 | |
| 0.508 | 0.004 | 0.508 | Estrogen receptor beta antagonist | 0.106 0.054 DBMET00592 0.124 0.028 DBMET00593 0.112 0.043 DBMET00601 | ||
| 0.502 | 0.002 | 0.502 | Estrogen receptor alpha agonist | 0.09 0.01 DBMET00592 0.193 0.005 DBMET00593 0.101 0.008 DBMET00601 | ||
| 0.489 | 0.005 | 0.528 | NOS3 expression enhancer | 0.307 0.017 DBMET00592 0.528 0.005 DBMET00593 0.337 0.013 DBMET00601 | DBMET00593 | |
| 0.49 | 0.006 | 0.599 | Interferon gamma antagonist | 0.599 0.002 DBMET00592 0.539 0.004 DBMET00593 0.596 0.003 DBMET00601 | DBMET00592 | |
| 0.486 | 0.009 | 0.486 | P-glycoprotein inhibitor | 0.266 0.037 DBMET00592 0.34 0.022 DBMET00593 0.321 0.025 DBMET00601 | ||
| 0.49 | 0.015 | 0.49 | DNA damaging | 0.191 0.123 DBMET00592 0.48 0.016 DBMET00593 0.256 0.077 DBMET00601 | ||
| 0.475 | 0.004 | 0.475 | Estrogen receptor alpha antagonist | 0.078 0.051 DBMET00601 | ||
| 0.473 | 0.005 | 0.473 | Growth factor agonist | 0.192 0.071 DBMET00592 0.227 0.043 DBMET00593 0.211 0.053 DBMET00601 | ||
| 0.467 | 0.026 | 0.522 | Caspase 3 stimulant | 0.457 0.028 DBMET00592 0.522 0.017 DBMET00593 0.478 0.024 DBMET00601 | DBMET00593 | |
| 0.459 | 0.018 | 0.581 | Tumour necrosis factor alpha release inhibitor | 0.465 0.018 DBMET00592 0.567 0.009 DBMET00593 0.581 0.008 DBMET00601 | DBMET00601 | |
| 0.445 | 0.017 | 0.56 | Interleukin 2 agonist | 0.56 0.004 DBMET00592 0.496 0.009 DBMET00593 0.56 0.004 DBMET00601 | DBMET00601 | |
| 0.425 | 0.001 | 0.425 | 5-Alpha-reductase 2 inhibitor | 0.149 0.004 DBMET00592 0.135 0.004 DBMET00593 0.135 0.004 DBMET00601 | ||
| 0.444 | 0.022 | 0.444 | Cardiotonic | 0.33 0.045 DBMET00592 0.399 0.029 DBMET00593 0.391 0.03 DBMET00601 | ||
| 0.423 | 0.004 | 0.452 | Cholesterol synthesis inhibitor | 0.452 0.003 DBMET00592 0.363 0.006 DBMET00593 0.447 0.003 DBMET00601 | DBMET00592 | |
| 0.417 | 0.002 | 0.417 | 5-Alpha-reductase inhibitor | 0.362 0.002 DBMET00592 0.252 0.004 DBMET00593 0.357 0.002 DBMET00601 | ||
| 0.425 | 0.017 | 0.425 | Calcium channel activator | |||
| 0.408 | 0.004 | 0.408 | Farnesoid X receptor antagonist | 0.204 0.02 DBMET00592 0.305 0.005 DBMET00593 0.241 0.013 DBMET00601 | ||
| 0.404 | 0.002 | 0.404 | 5-Alpha-reductase 1 inhibitor | 0.029 0.009 DBMET00592 0.023 0.01 DBMET00593 0.025 0.009 DBMET00601 | ||
| 0.415 | 0.017 | 0.731 | Interleukin agonist | 0.731 0.003 DBMET00592 0.668 0.004 DBMET00593 0.731 0.003 DBMET00601 | DBMET00601 | |
| 0.436 | 0.04 | 0.66 | Immunostimulant | 0.631 0.013 DBMET00592 0.658 0.011 DBMET00593 0.66 0.011 DBMET00601 | DBMET00601 | |
| 0.423 | 0.031 | 0.673 | Antioxidant | 0.634 0.009 DBMET00592 0.673 0.007 DBMET00593 0.635 0.009 DBMET00601 | DBMET00593 | |
| 0.393 | 0.003 | 0.393 | Progesterone antagonist | |||
| 0.378 | 0.002 | 0.378 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.033 0.021 DBMET00592 0.031 0.024 DBMET00593 0.033 0.021 DBMET00601 | ||
| 0.438 | 0.072 | 0.811 | Cyclophilin D inhibitor | 0.769 0.008 DBMET00592 0.811 0.006 DBMET00593 0.76 0.009 DBMET00601 | DBMET00593 | |
| 0.422 | 0.067 | 0.67 | Antibacterial | 0.67 0.011 DBMET00592 0.658 0.012 DBMET00593 0.661 0.012 DBMET00601 | DBMET00592 | |
| 0.378 | 0.027 | 0.378 | Antimitotic | 0.162 0.11 DBMET00593 | ||
| 0.35 | 0 | 0.35 | Transcortin receptor antagonist | 0.019 0.001 DBMET00592 0.009 0.003 DBMET00593 0.019 0.001 DBMET00601 | ||
| 0.345 | 0.003 | 0.345 | Bile acid receptor antagonist | 0.118 0.021 DBMET00592 0.233 0.004 DBMET00593 0.134 0.011 DBMET00601 | ||
| 0.381 | 0.05 | 0.464 | 5 Hydroxytryptamine release stimulant | 0.236 0.096 DBMET00592 0.464 0.033 DBMET00593 0.236 0.096 DBMET00601 | DBMET00593 | |
| 0.356 | 0.031 | 0.824 | Angiogenesis stimulant | 0.741 0.004 DBMET00592 0.824 0.004 DBMET00593 0.785 0.004 DBMET00601 | DBMET00593 | |
| 0.336 | 0.015 | 0.336 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.134 DBMET00593 0.222 0.057 DBMET00601 | ||
| 0.329 | 0.011 | 0.329 | Adenylate cyclase inhibitor | 0.208 0.024 DBMET00593 0.151 0.044 DBMET00601 | ||
| 0.317 | 0.001 | 0.317 | Arachidonic acid antagonist | 0.268 0.004 DBMET00592 0.24 0.008 DBMET00593 0.269 0.003 DBMET00601 | ||
| 0.317 | 0.005 | 0.317 | Beta tubulin antagonist | 0.05 0.047 DBMET00593 | ||
| 0.34 | 0.033 | 0.501 | DNA synthesis inhibitor | 0.421 0.019 DBMET00592 0.501 0.013 DBMET00593 0.498 0.014 DBMET00601 | DBMET00593 | |
| 0.332 | 0.026 | 0.332 | RNA-directed DNA polymerase inhibitor | 0.229 0.065 DBMET00592 0.276 0.038 DBMET00593 0.229 0.065 DBMET00601 | ||
| 0.33 | 0.025 | 0.524 | Platelet adhesion inhibitor | 0.474 0.006 DBMET00592 0.524 0.005 DBMET00593 0.468 0.007 DBMET00601 | DBMET00593 | |
| 0.3 | 0.003 | 0.3 | Aldosterone antagonist | |||
| 0.329 | 0.041 | 0.465 | Hypolipemic | 0.438 0.019 DBMET00592 0.465 0.016 DBMET00593 0.416 0.023 DBMET00601 | DBMET00593 | |
| 0.302 | 0.014 | 0.415 | Interleukin 6 antagonist | 0.314 0.013 DBMET00592 0.4 0.007 DBMET00593 0.415 0.007 DBMET00601 | DBMET00601 | |
| 0.325 | 0.042 | 0.325 | Transcription factor STAT3 inhibitor | 0.256 0.079 DBMET00592 0.288 0.059 DBMET00593 0.3 0.053 DBMET00601 | ||
| 0.286 | 0.004 | 0.286 | Alpha tubulin antagonist | 0.056 0.034 DBMET00593 | ||
| 0.267 | 0.005 | 0.272 | Microtubule formation inhibitor | 0.254 0.008 DBMET00592 0.272 0.004 DBMET00593 0.272 0.004 DBMET00601 | DBMET00601 | |
| 0.272 | 0.014 | 0.272 | DNA polymerase I inhibitor | 0.226 0.021 DBMET00592 0.257 0.016 DBMET00593 0.226 0.021 DBMET00601 | ||
| 0.261 | 0.004 | 0.261 | Adenylate cyclase stimulant | 0.162 0.045 DBMET00592 0.212 0.009 DBMET00593 0.178 0.027 DBMET00601 | ||
| 0.293 | 0.038 | 0.293 | Gastrin inhibitor | 0.226 0.11 DBMET00593 0.211 0.132 DBMET00601 | ||
| 0.287 | 0.035 | 0.287 | Growth hormone agonist | |||
| 0.254 | 0.003 | 0.254 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.296 | 0.058 | 0.296 | Transcription factor STAT inhibitor | 0.2 0.138 DBMET00592 0.225 0.107 DBMET00593 0.23 0.102 DBMET00601 | ||
| 0.238 | 0.003 | 0.339 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.339 0.002 DBMET00592 0.21 0.003 DBMET00593 0.293 0.002 DBMET00601 | DBMET00592 | |
| 0.251 | 0.016 | 0.503 | Alkylator | 0.218 0.022 DBMET00592 0.503 0.005 DBMET00593 0.365 0.009 DBMET00601 | DBMET00593 | |
| 0.236 | 0.002 | 0.505 | Na+ K+ transporting ATPase inhibitor | 0.505 0.001 DBMET00592 0.34 0.001 DBMET00593 0.504 0.001 DBMET00601 | DBMET00592 | |
| 0.236 | 0.003 | 0.391 | Glycine receptor antagonist | 0.334 0.002 DBMET00592 0.314 0.002 DBMET00593 0.391 0.001 DBMET00601 | DBMET00601 | |
| 0.249 | 0.025 | 0.249 | Bone formation stimulant | 0.152 0.057 DBMET00592 0.164 0.049 DBMET00593 0.181 0.041 DBMET00601 | ||
| 0.249 | 0.025 | 0.249 | Tubulin antagonist | |||
| 0.239 | 0.028 | 0.25 | Antipruritic | 0.18 0.065 DBMET00592 0.25 0.024 DBMET00601 | DBMET00601 | |
| 0.213 | 0.003 | 0.213 | Glucocorticoid antagonist | 0.078 0.007 DBMET00592 0.071 0.008 DBMET00593 0.14 0.004 DBMET00601 | ||
| 0.218 | 0.009 | 0.218 | Antineoplastic alkaloid | 0.079 0.066 DBMET00601 | ||
| 0.213 | 0.007 | 0.213 | Keratolytic | |||
| 0.209 | 0.004 | 0.209 | Mineralocorticoid receptor antagonist | 0.043 0.042 DBMET00593 0.06 0.02 DBMET00601 | ||
| 0.203 | 0.002 | 0.25 | Glucose-6-phosphate dehydrogenase inhibitor | 0.25 0.002 DBMET00592 0.094 0.003 DBMET00593 0.14 0.002 DBMET00601 | DBMET00592 | |
| 0.308 | 0.111 | 0.512 | Antiobesity | 0.512 0.035 DBMET00592 0.496 0.038 DBMET00593 0.417 0.059 DBMET00601 | DBMET00592 | |
| 0.2 | 0.006 | 0.2 | GABA receptor antagonist | |||
| 0.194 | 0.004 | 0.223 | Glycine receptor agonist | 0.123 0.012 DBMET00592 0.223 0.004 DBMET00593 0.123 0.012 DBMET00601 | DBMET00593 | |
| 0.186 | 0.003 | 0.186 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.183 | 0.005 | 0.183 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.066 0.02 DBMET00592 0.044 0.035 DBMET00601 | ||
| 0.203 | 0.026 | 0.237 | Neurotrophic factor | 0.188 0.033 DBMET00592 0.192 0.031 DBMET00593 0.237 0.015 DBMET00601 | DBMET00601 | |
| 0.252 | 0.075 | 0.652 | Hypoglycemic | 0.554 0.011 DBMET00592 0.652 0.006 DBMET00593 0.594 0.008 DBMET00601 | DBMET00593 | |
| 0.203 | 0.027 | 0.203 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 DBMET00592 0.181 0.033 DBMET00593 0.1 0.098 DBMET00601 | ||
| 0.211 | 0.037 | 0.477 | Melanin inhibitor | 0.477 0.008 DBMET00592 0.325 0.019 DBMET00593 0.464 0.008 DBMET00601 | DBMET00592 | |
| 0.21 | 0.037 | 0.356 | Lipid peroxidase inhibitor | 0.273 0.023 DBMET00592 0.356 0.012 DBMET00593 0.333 0.015 DBMET00601 | DBMET00593 | |
| 0.235 | 0.064 | 0.235 | Psychostimulant | 0.19 0.086 DBMET00592 0.165 0.104 DBMET00593 0.19 0.086 DBMET00601 | ||
| 0.176 | 0.009 | 0.176 | CDC25A inhibitor | 0.124 0.018 DBMET00592 0.098 0.028 DBMET00593 0.139 0.014 DBMET00601 | ||
| 0.176 | 0.014 | 0.176 | Prolactin inhibitor | |||
| 0.163 | 0.003 | 0.163 | Estrone sulfatase inhibitor | 0.061 0.006 DBMET00592 0.04 0.009 DBMET00593 0.061 0.006 DBMET00601 | ||
| 0.166 | 0.007 | 0.166 | GABA A receptor antagonist | |||
| 0.269 | 0.111 | 0.705 | Antithrombotic | 0.564 0.02 DBMET00592 0.705 0.008 DBMET00593 0.69 0.009 DBMET00601 | DBMET00593 | |
| 0.269 | 0.114 | 0.351 | Vasodilator, peripheral | 0.351 0.073 DBMET00593 0.213 0.162 DBMET00601 | DBMET00593 | |
| 0.157 | 0.003 | 0.157 | Progesterone agonist | 0.04 0.005 DBMET00592 0.033 0.006 DBMET00593 0.043 0.005 DBMET00601 | ||
| 0.153 | 0.004 | 0.153 | Estrogen-related receptor beta agonist | 0.08 0.066 DBMET00593 | ||
| 0.174 | 0.026 | 0.316 | Antineoplastic antibiotic | 0.316 0.009 DBMET00592 0.301 0.009 DBMET00593 0.285 0.01 DBMET00601 | DBMET00592 | |
| 0.183 | 0.034 | 0.194 | Protein-tyrosine phosphatase 1B inhibitor | 0.191 0.032 DBMET00592 0.194 0.031 DBMET00593 0.171 0.038 DBMET00601 | DBMET00593 | |
| 0.193 | 0.047 | 0.455 | Amylase inhibitor | 0.244 0.03 DBMET00592 0.455 0.007 DBMET00593 0.244 0.03 DBMET00601 | DBMET00593 | |
| 0.184 | 0.039 | 0.306 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET00592 0.306 0.015 DBMET00593 0.143 0.059 DBMET00601 | DBMET00593 | |
| 0.147 | 0.004 | 0.147 | Potassium channel Kv1.3 blocker | |||
| 0.235 | 0.096 | 0.235 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.159 | 0.026 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.143 0.064 DBMET00592 0.163 0.019 DBMET00593 0.143 0.064 DBMET00601 | DBMET00593 | |
| 0.143 | 0.011 | 0.143 | Alcohol oxidase inhibitor | |||
| 0.166 | 0.036 | 0.349 | Cyclooxygenase 3 inhibitor | 0.233 0.011 DBMET00592 0.349 0.005 DBMET00593 0.233 0.011 DBMET00601 | DBMET00593 | |
| 0.132 | 0.002 | 0.149 | Lipocortins synthesis agonist | 0.112 0.004 DBMET00592 0.111 0.004 DBMET00593 0.149 0.002 DBMET00601 | DBMET00601 | |
| 0.132 | 0.003 | 0.132 | Farnesoid X receptor agonist | 0.053 0.013 DBMET00593 0.059 0.01 DBMET00601 | ||
| 0.143 | 0.018 | 0.266 | Transcription factor NF kappa B stimulant | 0.266 0.005 DBMET00592 0.242 0.006 DBMET00593 0.221 0.008 DBMET00601 | DBMET00592 | |
| 0.152 | 0.027 | 0.619 | AMP-activated protein kinase stimulant | 0.304 0.005 DBMET00592 0.558 0.003 DBMET00593 0.619 0.003 DBMET00601 | DBMET00601 | |
| 0.164 | 0.043 | 0.164 | Anesthetic local | |||
| 0.174 | 0.053 | 0.476 | Protein kinase stimulant | 0.476 0.005 DBMET00592 0.317 0.015 DBMET00593 0.412 0.007 DBMET00601 | DBMET00592 | |
| 0.153 | 0.034 | 0.511 | Expectorant | 0.275 0.01 DBMET00592 0.511 0.004 DBMET00593 0.379 0.005 DBMET00601 | DBMET00593 | |
| 0.123 | 0.006 | 0.123 | Botulinum neurotoxin type A inhibitor | |||
| 0.138 | 0.024 | 0.138 | Acetylcholine nicotinic antagonist | |||
| 0.148 | 0.037 | 0.148 | GABA receptor agonist | |||
| 0.144 | 0.036 | 0.207 | Mucolytic | 0.12 0.054 DBMET00592 0.207 0.012 DBMET00593 0.144 0.036 DBMET00601 | DBMET00593 | |
| 0.135 | 0.03 | 0.135 | Hedgehog signaling inhibitor | |||
| 0.107 | 0.004 | 0.107 | Adenylate cyclase 1 inhibitor | |||
| 0.166 | 0.065 | 0.171 | Protein-tyrosine phosphatase inhibitor | 0.165 0.065 DBMET00592 0.171 0.062 DBMET00593 0.15 0.079 DBMET00601 | DBMET00593 | |
| 0.124 | 0.023 | 0.124 | Ornithine decarboxylase inhibitor | 0.08 0.068 DBMET00593 | ||
| 0.122 | 0.023 | 0.122 | Opioid kappa receptor antagonist | |||
| 0.208 | 0.113 | 0.374 | Spasmolytic | 0.374 0.046 DBMET00592 0.358 0.05 DBMET00593 0.272 0.082 DBMET00601 | DBMET00592 | |
| 0.168 | 0.074 | 0.318 | ATPase inhibitor | 0.269 0.01 DBMET00592 0.318 0.005 DBMET00593 0.229 0.02 DBMET00601 | DBMET00593 | |
| 0.194 | 0.102 | 0.517 | Free radical scavenger | 0.459 0.02 DBMET00592 0.517 0.015 DBMET00593 0.497 0.016 DBMET00601 | DBMET00593 | |
| 0.094 | 0.004 | 0.094 | Pregnane X receptor antagonist | |||
| 0.128 | 0.038 | 0.176 | UDP-glucose 4-epimerase inhibitor | 0.148 0.029 DBMET00592 0.176 0.022 DBMET00593 0.148 0.029 DBMET00601 | DBMET00593 | |
| 0.116 | 0.026 | 0.116 | GABA A receptor agonist | |||
| 0.096 | 0.008 | 0.129 | Heme oxygenase stimulant | 0.129 0.004 DBMET00592 0.072 0.023 DBMET00593 0.068 0.028 DBMET00601 | DBMET00592 | |
| 0.116 | 0.035 | 0.116 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.091 | 0.01 | 0.091 | Opioid kappa receptor agonist | |||
| 0.087 | 0.009 | 0.087 | Carbonic anhydrase IV inhibitor | |||
| 0.172 | 0.094 | 0.284 | Non-steroidal antiinflammatory agent | 0.173 0.093 DBMET00592 0.284 0.032 DBMET00593 0.279 0.033 DBMET00601 | DBMET00593 | |
| 0.095 | 0.018 | 0.095 | Phospholipase D inhibitor | 0.079 0.035 DBMET00593 | ||
| 0.078 | 0.004 | 0.078 | Microtubule stabilization | 0.059 0.016 DBMET00592 0.072 0.006 DBMET00593 0.065 0.01 DBMET00601 | ||
| 0.149 | 0.078 | 0.149 | CF transmembrane conductance regulator agonist | |||
| 0.08 | 0.01 | 0.08 | Acetyl-CoA transferase 2 inhibitor | 0.056 0.041 DBMET00592 0.067 0.021 DBMET00593 0.056 0.041 DBMET00601 | ||
| 0.065 | 0.002 | 0.065 | Hedgehog signaling activator | 0.031 0.011 DBMET00593 | ||
| 0.063 | 0.003 | 0.115 | Ileal bile acid transport inhibitor | 0.057 0.003 DBMET00592 0.115 0.002 DBMET00593 0.074 0.003 DBMET00601 | DBMET00593 | |
| 0.121 | 0.061 | 0.121 | Interleukin 8 antagonist | |||
| 0.062 | 0.004 | 0.083 | Glucocorticoid agonist | 0.046 0.005 DBMET00592 0.013 0.009 DBMET00593 0.083 0.003 DBMET00601 | DBMET00601 | |
| 0.125 | 0.069 | 0.125 | Cholinergic antagonist | |||
| 0.059 | 0.002 | 0.059 | Vitamin D receptor agonist | 0.023 0.005 DBMET00592 0.03 0.004 DBMET00593 0.02 0.007 DBMET00601 | ||
| 0.212 | 0.156 | 0.314 | Angiogenesis inhibitor | 0.203 0.166 DBMET00592 0.314 0.086 DBMET00593 0.209 0.159 DBMET00601 | DBMET00593 | |
| 0.123 | 0.068 | 0.123 | Acetylcholine antagonist | |||
| 0.102 | 0.047 | 0.102 | ABCA1 expression enhancer | |||
| 0.128 | 0.078 | 0.163 | CC chemokine 6 receptor antagonist | 0.148 0.025 DBMET00592 0.163 0.011 DBMET00593 0.155 0.017 DBMET00601 | DBMET00593 | |
| 0.05 | 0.003 | 0.091 | Corticosteroid-like | 0.057 0.003 DBMET00592 0.038 0.004 DBMET00593 0.091 0.002 DBMET00601 | DBMET00601 | |
| 0.058 | 0.011 | 0.058 | GABA uptake inhibitor | |||
| 0.053 | 0.007 | 0.053 | Tubulin agonist | 0.036 0.021 DBMET00593 | ||
| 0.042 | 0.002 | 0.067 | Telomerase stimulant | 0.049 0.001 DBMET00592 0.067 0.001 DBMET00593 0.065 0.001 DBMET00601 | DBMET00593 | |
| 0.054 | 0.016 | 0.054 | Parathyroid hormone antagonist | |||
| 0.088 | 0.05 | 0.088 | Inducible nitric-oxide synthase inhibitor | |||
| 0.108 | 0.07 | 0.364 | Monophenol monooxygenase inhibitor | 0.17 0.04 DBMET00592 0.228 0.027 DBMET00593 0.364 0.013 DBMET00601 | DBMET00601 | |
| 0.06 | 0.023 | 0.364 | Heparanase inhibitor | 0.202 0.002 DBMET00592 0.364 0.001 DBMET00593 0.202 0.002 DBMET00601 | DBMET00593 | |
| 0.067 | 0.031 | 0.067 | Carbonic anhydrase II inhibitor | 0.061 0.034 DBMET00593 | ||
| 0.042 | 0.009 | 0.042 | Estrogen-related receptor beta antagonist | |||
| 0.055 | 0.023 | 0.055 | Cholesterol esterase inhibitor | |||
| 0.075 | 0.044 | 0.176 | Phosphofructokinase-1 inhibitor | 0.107 0.029 DBMET00592 0.176 0.014 DBMET00593 0.107 0.029 DBMET00601 | DBMET00593 | |
| 0.099 | 0.069 | 0.099 | Adenylate kinase inhibitor | |||
| 0.063 | 0.034 | 0.063 | Argininosuccinate synthase inhibitor | |||
| 0.042 | 0.015 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.049 0.008 DBMET00593 | DBMET00593 | |
| 0.057 | 0.031 | 0.108 | Alpha-mannosidase inhibitor | 0.066 0.02 DBMET00592 0.108 0.005 DBMET00593 0.077 0.012 DBMET00601 | DBMET00593 | |
| 0.039 | 0.015 | 0.039 | HMG CoA reductase inhibitor | 0.034 0.025 DBMET00593 | ||
| 0.051 | 0.028 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET00592 0.068 0.013 DBMET00593 0.047 0.034 DBMET00601 | DBMET00593 | |
| 0.03 | 0.007 | 0.03 | Vitamin D receptor antagonist | 0.022 0.015 DBMET00592 0.025 0.01 DBMET00593 0.023 0.014 DBMET00601 | ||
| 0.025 | 0.002 | 0.025 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 DBMET00592 0.013 0.008 DBMET00593 0.013 0.007 DBMET00601 | ||
| 0.081 | 0.06 | 0.081 | T cell inhibitor | |||
| 0.064 | 0.043 | 0.067 | Carbonic anhydrase inhibitor | 0.067 0.041 DBMET00593 | DBMET00593 | |
| 0.05 | 0.03 | 0.11 | Phosphorylase inhibitor | 0.041 0.036 DBMET00592 0.11 0.012 DBMET00593 0.103 0.013 DBMET00601 | DBMET00593 | |
| 0.066 | 0.047 | 0.066 | Glutamate (mGluR6) antagonist | |||
| 0.083 | 0.064 | 0.083 | Hematopoietic | |||
| 0.095 | 0.078 | 0.161 | Toll-Like receptor 4 antagonist | 0.156 0.018 DBMET00592 0.161 0.016 DBMET00593 0.156 0.018 DBMET00601 | DBMET00593 | |
| 0.168 | 0.151 | 0.41 | Peptidyltransferase inhibitor | 0.377 0.009 DBMET00592 0.41 0.006 DBMET00593 0.377 0.009 DBMET00601 | DBMET00593 | |
| 0.053 | 0.037 | 0.138 | Protein 50S ribosomal subunit inhibitor | 0.127 0.009 DBMET00592 0.138 0.007 DBMET00593 0.119 0.009 DBMET00601 | DBMET00593 | |
| 0.084 | 0.069 | 0.124 | Triose-phosphate isomerase inhibitor | 0.086 0.066 DBMET00592 0.124 0.03 DBMET00593 0.086 0.066 DBMET00601 | DBMET00593 | |
| 0.085 | 0.072 | 0.085 | Breast cancer-resistant protein inhibitor | |||
| 0.085 | 0.074 | 0.12 | Glutamate release inhibitor | 0.12 0.022 DBMET00593 | DBMET00593 | |
| 0.037 | 0.025 | 0.037 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.024 | 0.014 | 0.024 | Prostaglandin F2 alpha agonist | |||
| 0.039 | 0.031 | 0.039 | Liver X receptor alpha agonist | |||
| 0.083 | 0.076 | 0.115 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.115 0.042 DBMET00593 | DBMET00593 | |
| 0.121 | 0.116 | 0.121 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.091 | 0.086 | 0.167 | Beta glucuronidase inhibitor | 0.095 0.079 DBMET00592 0.167 0.019 DBMET00593 0.135 0.033 DBMET00601 | DBMET00593 | |
| 0.054 | 0.05 | 0.054 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.08 | 0.076 | 0.126 | NADH dehydrogenase inhibitor | 0.086 0.064 DBMET00592 0.126 0.026 DBMET00593 0.086 0.064 DBMET00601 | DBMET00593 | |
| 0.015 | 0.011 | 0.015 | Antibiotic Tetracycline-like | |||
| 0.03 | 0.026 | 0.03 | Estrogen-related receptor alpha antagonist | |||
| 0.077 | 0.074 | 0.077 | Opioid antagonist | |||
| 0.015 | 0.013 | 0.015 | Thromboxane A2 agonist | |||
| 0.153 | 0.152 | 0.392 | Vasodilator | 0.344 0.035 DBMET00592 0.392 0.024 DBMET00593 0.342 0.035 DBMET00601 | DBMET00593 | |
| 0.118 | 0.119 | 0.406 | Hemostatic | 0.266 0.02 DBMET00592 0.406 0.007 DBMET00593 0.323 0.014 DBMET00601 | DBMET00593 | |
| 0.038 | 0.043 | 0.093 | Mannosidase inhibitor | 0.051 0.025 DBMET00592 0.093 0.006 DBMET00593 0.062 0.015 DBMET00601 | DBMET00593 | |
| 0.115 | 0.12 | 0.352 | Insulin secretagoues | 0.196 0.038 DBMET00592 0.352 0.008 DBMET00593 0.261 0.018 DBMET00601 | DBMET00593 | |
| 0.019 | 0.025 | 0.072 | Protein 30S ribosomal subunit inhibitor | 0.061 0.006 DBMET00592 0.072 0.005 DBMET00593 0.072 0.005 DBMET00601 | DBMET00601 | |
| 0.198 | 0.205 | 0.46 | Histamine release inhibitor | 0.322 0.112 DBMET00592 0.46 0.045 DBMET00593 0.322 0.112 DBMET00601 | DBMET00593 | |
| 0.021 | 0.03 | 0.039 | Vanilloid 2 agonist | 0.027 0.014 DBMET00592 0.039 0.004 DBMET00593 0.027 0.014 DBMET00601 | DBMET00593 | |
| 0.023 | 0.04 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.022 DBMET00592 0.031 0.012 DBMET00593 0.028 0.021 DBMET00601 | DBMET00593 | |
| 0.005 | 0.024 | 0.019 | Antibiotic Macrolide-like | 0.015 0.009 DBMET00592 0.019 0.007 DBMET00593 0.016 0.009 DBMET00601 | DBMET00593 | |
| 0.014 | 0.034 | 0.023 | Antibiotic Anthracycline-like | 0.02 0.01 DBMET00592 0.023 0.006 DBMET00593 0.02 0.01 DBMET00601 | DBMET00593 | |
| 0.05 | 0.07 | 0.094 | Nitric oxide donor | 0.076 0.026 DBMET00592 0.082 0.02 DBMET00593 0.094 0.012 DBMET00601 | DBMET00601 | |
| 0.029 | 0.058 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.028 DBMET00593 | DBMET00593 | |
| 0.026 | 0.056 | 0.085 | Antibiotic Aminoglycoside-like | 0.074 0.005 DBMET00592 0.085 0.004 DBMET00593 0.074 0.005 DBMET00601 | DBMET00593 | |
| 0.072 | 0.104 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 DBMET00601 | DBMET00601 | |
| 0.138 | 0.175 | 0.323 | Cyclic AMP phosphodiesterase inhibitor | 0.197 0.096 DBMET00592 0.323 0.033 DBMET00593 0.197 0.096 DBMET00601 | DBMET00593 | |
| 0.085 | 0.123 | 0.121 | Photosensitizer | 0.121 0.056 DBMET00593 | DBMET00593 | |
| 0.168 | 0.215 | 0.376 | Vasodilator, coronary | 0.234 0.15 DBMET00592 0.376 0.044 DBMET00593 0.234 0.15 DBMET00601 | DBMET00593 | |
| 0.014 | 0.062 | 0.041 | Sodium/glucose cotransporter 2 inhibitor | 0.041 0.008 DBMET00593 | DBMET00593 | |
| 0.074 | 0.137 | 0.148 | Multidrug resistance-associated protein 1 inhibitor | 0.118 0.051 DBMET00592 0.148 0.026 DBMET00593 0.118 0.051 DBMET00601 | DBMET00593 | |
| 0.014 | 0.08 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 DBMET00593 | DBMET00593 | |
| 0.043 | 0.119 | 0.132 | Topoisomerase II alpha inhibitor | 0.094 0.043 DBMET00592 0.132 0.027 DBMET00593 0.094 0.043 DBMET00601 | DBMET00593 | |
| 0.006 | 0.109 | 0.044 | Arginase inhibitor | 0.044 0.019 DBMET00593 | DBMET00593 | |
| 0.024 | 0.143 | 0.356 | Selectin antagonist | 0.306 0.005 DBMET00592 0.356 0.004 DBMET00593 0.314 0.005 DBMET00601 | DBMET00593 | |
| 0.073 | 0.225 | 0.227 | Cell wall synthesis inhibitor | 0.227 0.021 DBMET00593 | DBMET00593 | |
| 0.043 | 0.203 | 0.102 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 DBMET00592 0.102 0.037 DBMET00593 0.091 0.054 DBMET00601 | DBMET00593 | |
| 0.035 | 0.197 | 0.207 | Topoisomerase I inhibitor | 0.156 0.039 DBMET00592 0.207 0.025 DBMET00593 0.161 0.037 DBMET00601 | DBMET00593 | |
| 0.072 | 0.25 | 0.131 | Hexokinase inhibitor | 0.131 0.103 DBMET00593 | DBMET00593 | |
| 0.061 | 0.24 | 0.262 | Cell adhesion inhibitor | 0.164 0.038 DBMET00592 0.262 0.013 DBMET00593 0.235 0.017 DBMET00601 | DBMET00593 | |
| 0.121 | 0.302 | 0.449 | Immunomodulator | 0.35 0.06 DBMET00592 0.449 0.031 DBMET00593 0.403 0.043 DBMET00601 | DBMET00593 | |
| 0.022 | 0.234 | 0.072 | Glucose-6-phosphate translocase inhibitor | 0.059 0.025 DBMET00592 0.072 0.015 DBMET00593 0.064 0.02 DBMET00601 | DBMET00593 | |
| 0.015 | 0.229 | 0.044 | Neuraminidase (Influenza A) inhibitor | 0.044 0.034 DBMET00593 | DBMET00593 | |
| 0.02 | 0.244 | 0.069 | Neuraminidase (influenza) inhibitor | 0.069 0.036 DBMET00593 | DBMET00593 | |
| 0.043 | 0.281 | 0.147 | Beta amyloid protein antagonist | 0.147 0.042 DBMET00593 0.105 0.083 DBMET00601 | DBMET00593 | |
| 0.028 | 0.313 | 0.181 | Topoisomerase II inhibitor | 0.137 0.056 DBMET00592 0.181 0.038 DBMET00593 0.127 0.062 DBMET00601 | DBMET00593 | |
| 0.01 | 0.314 | 0.054 | Neuraminidase inhibitor | 0.054 0.051 DBMET00593 | DBMET00593 | |
| 0.013 | 0.346 | 0.032 | Toll-Like receptor 4 agonist | 0.028 0.015 DBMET00592 0.032 0.009 DBMET00593 0.028 0.015 DBMET00601 | DBMET00593 | |
| 0.026 | 0.381 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.035 DBMET00593 | DBMET00593 | |
| 0.035 | 0.402 | 0.086 | Interleukin 5 antagonist | 0.086 0.06 DBMET00601 | DBMET00601 | |
| 0.038 | 0.426 | 0.299 | Platelet antagonist | 0.186 0.112 DBMET00592 0.299 0.053 DBMET00593 0.247 0.074 DBMET00601 | DBMET00593 | |
| 0.047 | 0.469 | 0.124 | DNA repair enzyme inhibitor | 0.107 0.104 DBMET00592 0.124 0.065 DBMET00601 | DBMET00601 | |
| 0.022 | 0.46 | 0.089 | Uric acid excretion stimulant | 0.089 0.066 DBMET00593 | DBMET00593 | |
| 0.019 | 0.526 | 0.313 | Thrombolytic | 0.222 0.042 DBMET00592 0.313 0.022 DBMET00593 0.26 0.031 DBMET00601 | DBMET00593 | |
| 0.036 | 0.642 | 0.369 | Toll-Like receptor 7 agonist | 0.369 0.073 DBMET00601 | DBMET00601 | |
| 0.033 | 0.658 | 0.38 | Toll-Like receptor agonist | 0.38 0.068 DBMET00601 | DBMET00601 | |
| 0.012 | 0.65 | 0.081 | Histone deacetylase stimulant | 0.065 0.061 DBMET00593 0.081 0.042 DBMET00601 | DBMET00601 | |
| 0.012 | 0.65 | 0.081 | Histone deacetylase SIRT1 stimulant | 0.065 0.061 DBMET00593 0.081 0.042 DBMET00601 | DBMET00601 | |
| 0.004 | 0.731 | 0.023 | Motilin receptor agonist | 0.023 0.015 DBMET00593 | DBMET00593 | |
| 0.008 | 0.937 | 0.052 | Factor IXa inhibitor | 0.052 0.034 DBMET00593 | DBMET00593 | |
| 0.004 | 0.939 | 0.162 | Anticoagulant | 0.162 0.071 DBMET00593 | DBMET00593 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |